Predictive value of prognostic nutritional index (PNI) in recurrent or unresectable hepatocellular carcinoma received anti-PD1 therapy

Chia sẻ: _ _ | Ngày: | Loại File: PDF | Số trang:14

Thêm vào BST

Báo xấu

10
lượt xem 3
download

Download Vui lòng tải xuống để xem tài liệu đầy đủ

Clinical trials have shown that anti-PD1 therapy, either as a monotherapy or in combination, is effective and well-tolerated in patients with recurrent or unresectable hepatocellular carcinoma (HCC). In this study, we aimed to investigate the prognostic value of immune-nutritional biomarkers in measuring the effects of anti-PD1 therapy in these patients.

Chủ đề: